N of 1 trial of On-Demand Sildenafil in Raynauds (multiple crossovers in single patient) shows in 38 pts there was a 90% chance of response w/ sildenafil superior to placebo; but substantial heterogeneity of patient responses limits the clinical relevance. https://t.co/FCllFm1FLR